Korro Bio (KRRO)
Develops RNA-editing therapeutics around OPERA and GalNAc-delivered liver programs.
$9.99
vs last close−0.36 (−3.43%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 49 days
EPS estimate
−$1.25
Revenue estimate
$187.5K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$2.26−$2.49−$2.74−$1.92−$5.32−$1.69−$1.07Pending
Estimate−$2.33−$2.60−$2.54−$2.61−$1.93−$1.60−$1.34−$1.25
Surprise+3.0%+4.2%−7.9%+26.4%−175.6%−5.6%+20.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$2.3M$2.6M$1.5M$1.1M$1.3M—$1.5MPending
Estimate—$426.9K$320.8K$425.0K$700.0K$761.2K$214.3K$187.5K
Surprise—+497.3%+355.1%+156.5%+85.7%—+600.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.12 | — | — |
| Sep 2027 | −$1.09 | — | — |
| Jun 2027 | −$1.08 | — | — |
| Mar 2027 | −$1.41 | — | — |
| Dec 2026 | −$1.29 | — | — |
| Nov 2026 | −$1.25 | — | — |
| Aug 2026 | −$1.34 | −$1.07 | +20.1% |
| May 2026 | −$1.60 | −$1.69 | −5.6% |
| Mar 2026 | −$1.93 | −$5.32 | −175.6% |
| Nov 2025 | −$2.61 | −$1.92 | +26.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Nov 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.12 | — | — | $300.0K | — | — | — |
| Sep 2027 | −$1.09 | — | — | $300.0K | — | — | — |
| Jun 2027 | −$1.08 | — | — | $166.7K | — | — | — |
| Mar 2027 | −$1.41 | — | — | $500.0K | — | — | — |
| Dec 2026 | −$1.29 | — | — | $187.5K | — | — | — |
| Nov 11, 2026 | −$1.25 | — | — | $187.5K | — | — | — |
| Aug 6, 2026 | −$1.34 | −$1.07 | +20.1% | $214.3K | $1.5M | +600.0% | +5.4% |
| May 7, 2026 | −$1.60 | −$1.69 | −5.6% | $761.2K | — | — | −3.4% |
| Mar 12, 2026 | −$1.93 | −$5.32 | −175.6% | $700.0K | $1.3M | +85.7% | −2.2% |
| Nov 12, 2025 | −$2.61 | −$1.92 | +26.4% | $425.0K | $1.1M | +156.5% | −4.2% |
| Aug 12, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 26, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 10, 2023 | |||||||
| Dec 30, 2022 | |||||||
| Nov 8, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Sep 29, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 |